Disc Medicine, Inc.
Disc Medicine, Inc. (IRON) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IRON · as of Jun 8, 2026
Key Statistics
Explore Disc Medicine, Inc. Data
iron stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 100.0%
The IRON analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $103.33, representing +54.22% upside from the current price of $67.00.
Competitors & Peers
iron competitorsIRON
AAPG
ADPT
APGE
CELC
CGONStock Performance
Full HistoryAbout Disc Medicine, Inc.
Disc Medicine, Inc. a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It b…
what is disc medicine, inc. · iron stock overview · disc medicine, inc. company profile · who is disc medicine, inc. ceo · iron NASDAQ · disc medicine, inc. headquarters · disc medicine, inc. business segments
About Stock Overview & Key Data
Disc Medicine, Inc. (IRON) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 12, 2020. As of the latest trading session, IRON stock price is $67.00, with a market capitalization of $2.6B. The stock has returned +30.30% over the past 12 months and -15.63% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Disc Medicine, Inc. stock is Buy, with an average 12-month price target of $103.33. In fiscal year 2025, Disc Medicine, Inc. reported revenue of — and net income of -$212.2M. For detailed data — including Disc Medicine, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Disc Medicine, Inc. (IRON) stock price is $67.00. The stock is traded on NASDAQ under the ticker symbol IRON. The 52-week range is $40.00 – $99.50.